IRIS
GALIERO, RAFFAELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.235
AS - Asia 1.221
NA - Nord America 644
SA - Sud America 185
AF - Africa 10
Totale 3.295
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 733
US - Stati Uniti d'America 626
SG - Singapore 418
CN - Cina 319
HK - Hong Kong 198
IT - Italia 193
BR - Brasile 156
IE - Irlanda 121
KR - Corea 81
DE - Germania 63
VN - Vietnam 63
IN - India 61
JP - Giappone 23
GB - Regno Unito 21
FR - Francia 19
ID - Indonesia 11
AT - Austria 10
FI - Finlandia 10
MX - Messico 9
PL - Polonia 9
AR - Argentina 8
NL - Olanda 8
AE - Emirati Arabi Uniti 6
CA - Canada 6
CO - Colombia 6
CZ - Repubblica Ceca 6
PK - Pakistan 6
TR - Turchia 6
LT - Lituania 5
SE - Svezia 5
UA - Ucraina 5
VE - Venezuela 5
EC - Ecuador 4
ES - Italia 4
IL - Israele 4
MA - Marocco 4
BD - Bangladesh 3
BE - Belgio 3
CH - Svizzera 3
IR - Iran 3
PT - Portogallo 3
ZA - Sudafrica 3
BO - Bolivia 2
EG - Egitto 2
GE - Georgia 2
GR - Grecia 2
IQ - Iraq 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
MO - Macao, regione amministrativa speciale della Cina 2
PE - Perù 2
RO - Romania 2
RS - Serbia 2
UZ - Uzbekistan 2
AL - Albania 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
DK - Danimarca 1
DM - Dominica 1
EE - Estonia 1
JM - Giamaica 1
JO - Giordania 1
LB - Libano 1
LV - Lettonia 1
NO - Norvegia 1
PY - Paraguay 1
SA - Arabia Saudita 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TW - Taiwan 1
UY - Uruguay 1
Totale 3.295
Salva come PNG Salva come JPEG
Città #
Moscow 259
Singapore 201
Hong Kong 197
Santa Clara 121
Dublin 115
Hefei 101
The Dalles 84
Seoul 81
Naples 72
New York 49
Bengaluru 48
Chandler 43
Ashburn 41
Munich 34
Beijing 31
Ho Chi Minh City 25
Dallas 20
São Paulo 18
Los Angeles 15
Hanoi 10
Salerno 9
Amsterdam 8
Falkenstein 8
Belo Horizonte 7
Brooklyn 7
Liveri 7
Atlanta 6
Bexley 6
Boardman 6
Cambridge 6
Florence 6
Milan 6
Princeton 6
Roxbury 6
Boston 5
Brno 5
Ercolano 5
Frankfurt am Main 5
Helsinki 5
Lahore 5
Stockholm 5
Vienna 5
Chennai 4
Guarulhos 4
Istanbul 4
Nuremberg 4
Paris 4
Rio de Janeiro 4
San Francisco 4
Warsaw 4
Boydton 3
Bremen 3
Brussels 3
Campinas 3
Chicago 3
Denver 3
Lappeenranta 3
London 3
Mexico City 3
Mumbai 3
Olbia 3
Pelotas 3
Porto Alegre 3
Roubaix 3
Shenzhen 3
Tel Aviv 3
Terzigno 3
Toronto 3
Wroclaw 3
Zurich 3
Athens 2
Avellino 2
Baghdad 2
Banda Aceh 2
Belgrade 2
Bishkek 2
Biên Hòa 2
Bogotá 2
Brasília 2
Bắc Giang 2
Bắc Ninh 2
Cagliari 2
Camden 2
Can Tho 2
Casablanca 2
Changsha 2
Crispano 2
Dhaka 2
Ecatepec 2
Francisco Morato 2
Guastalla 2
Guayaquil 2
Haiphong 2
Hanover 2
Itaquaquecetuba 2
Jacksonville 2
Johannesburg 2
La Paz 2
Lisbon 2
Loreto Aprutino 2
Totale 1.851
Salva come PNG Salva come JPEG
Nome #
ULTRASOUND TIPS IN THE LUNG CANCER DIAGNOSIS: A PILOT STUDY 110
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 108
Cardiac Hypertrophy: from Pathophysiological Mechanisms to Heart Failure Development 104
null 93
Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study 88
Comment on: Effect of Vitamin D supplementation in patients with liver cirrhosis having spontaneous bacterial peritonitis: a randomized controlled study 87
Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes 86
Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes 84
Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options 84
Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options 81
Left bundle branch pacing and cardiac remodeling in HF patients with type 2 diabetes mellitus: epigenetic pathways and clinical outcomes 79
GLP-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: Current Evidence and Future Perspectives 79
Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: A pilot prospective study. GLISCAR study 77
Comment on: Warfarin adherence and anticoagulation control in atrial fibrillation patients-a systematic review 76
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study 74
Liver Involvement in Patients With Systemic Sclerosis: Role of Transient Elastography in the Assessment of Hepatic Fibrosis and Steatosis 73
The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial 71
CURRENT HEPATOCELLULAR CARCINOMA SYSTEMIC PHARMACOLOGICAL TREATMENT OPTIONS 70
An Update on Betrixaban, the Challenging Anticoagulant Agent for Extended Venous Thromboembolism Prophylaxis 69
Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study 68
Diabetic Gastroparesis: Navigating Pathophysiology and Nutritional Interventions 68
Polypharmacy and major adverse events in atrial fibrillation 67
Non-alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes, and Non-viral Hepatocarcinoma: Pathophysiological Mechanisms and New Therapeutic Strategies 66
Optimizing Anticoagulation Management in Atrial Fibrillation: Beyond the Guidelines. How and for Whom? 65
Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease 65
Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications 65
EFFICACY OF COVID-19 VACCINATION IN PATIENTS WITH IMMUNE SYSTEM DISORDERS AND CANCER 64
Sex-difference of multifactorial intervention on cardiovascular and mortality risk in DKD: post-hoc analysis of a randomised clinical trial 63
Advances in the Insulin-Heart Axis: Current Therapies and Future Directions 62
Advances in Pharmacological Approaches for Managing Hypercholesterolemia: A Comprehensive Overview of Novel Treatments 61
ULTRASOUND TIPS IN THE LUNG CANCER DIAGNOSIS: A PILOT STUDY 60
The Significance of Statin-Associated Muscle Symptoms and Its Impact on Patient Adherence and Outcomes 59
Modern Challenges in Type 2 Diabetes: Balancing New Medications with Multifactorial Care 57
Effects of Metformin in Heart Failure: From Pathophysiological Rationale to Clinical Evidence 57
Cardiovascular Benefits from Gliflozins: Effects on Endothelial Function 56
Assessment of the Effectiveness of Ticagrelor Preloading in Mitigating Periprocedural Myocardial Injury Among Non-ST Elevation Myocardial Infarction Patients Opting for an Early Invasive Approach 56
Predictive Value of Fatty Liver Index for Long-Term Cardiovascular Events in Patients Receiving Liver Transplantation: The COLT Study 56
The Role of Neuropathy Screening Tools in Patients Affected by Fibromyalgia 56
Insulin–Heart Axis: Bridging Physiology to Insulin Resistance 55
Impact of liver fibrosis on COVID-19 in-hospital mortality in Southern Italy 55
Late Hepatocellular Carcinoma Occurrence in Patients Achieving Sustained Virological Response After Direct-Acting Antiviral Therapy: A Matter of Follow-Up or Something Else? 54
Saxagliptin/dapagliflozin is non‐inferior to insulin glargine in terms of β‐cell function in subjects with latent autoimmune diabetes in adults: A 12‐month, randomized, comparator‐controlled pilot study 53
The Role of Lung Ultrasound in SARS-CoV-19 Pneumonia Management 52
The impact of new onset diabetes on cardiovascular risks in orthotopic liver transplant recipients: findings from the COLT study 51
NerveCheck master to screen patients with type 1 or type 2 diabetes for peripheral and cardiac autonomic neuropathy 50
Changes in clinical scenarios, management, and perspectives of patients with chronic hepatitis C after viral clearance by direct-acting antivirals 50
The Diabetic Cardiomyopathy: The Contributing Pathophysiological Mechanisms 44
Precision Medicine in Type 2 Diabetes Mellitus: Utility and Limitations 39
Remdesivir treatment and clinical outcome in non-severe hospitalized COVID-19 patients: a propensity score matching multicenter Italian hospital experience 38
Impact of Gliflozins on Right Heart Remodeling in Italian Patients with Type 2 Diabetes and Heart Failure: Results from the GLISCAR Real-World Study 33
Does a strict glycemic control during acute coronary syndrome play a cardioprotective effect? Pathophysiology and clinical evidence 20
Impact of empagliflozin as add-on to metformin vs metformin continuation on MASLD progression in type 2 diabetes: The IMAGIN Study 13
Totale 3.371
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.447
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.447
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202246 1 0 0 2 2 0 2 1 9 1 8 20
2022/2023221 11 12 4 10 27 11 5 8 105 10 7 11
2023/2024276 26 13 9 24 51 45 8 9 7 25 26 33
2024/2025984 4 14 3 24 156 98 126 93 164 105 89 108
2025/20261.844 251 308 244 147 407 487 0 0 0 0 0 0
Totale 3.371